Literature DB >> 12037155

Can we change the course of beta-cell destruction in type 1 diabetes?

Edwin A M Gale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12037155     DOI： 10.1056/NEJM200205303462211

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

Review 1.  The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure.

Authors:  Bart O Roep
Journal:  Diabetologia       Date:  2003-03-22       Impact factor: 10.122

Review 2.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: immune therapies of type 1 diabetes: new opportunities based on the hygiene hypothesis.

Authors:  L Chatenoud; S You; H Okada; C Kuhn; B Michaud; J-F Bach
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

Review 3.  Understanding immunology via engineering design: the role of mathematical prototyping.

Authors:  David J Klinke; Qing Wang
Journal:  Comput Math Methods Med       Date:  2012-09-03       Impact factor: 2.238

4.  Antigen-specific immunotherapy for type 1 diabetes: maximizing the potential.

Authors:  Mark Peakman; Matthias von Herrath
Journal:  Diabetes       Date:  2010-09       Impact factor: 9.461

5.  Age-corrected beta cell mass following onset of type 1 diabetes mellitus correlates with plasma C-peptide in humans.

Authors:  David J Klinke
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

6.  Immune Checkpoint Inhibitor-Associated Type 1 Diabetes Mellitus: Case Series, Review of the Literature, and Optimal Management.

Authors:  Jonathan Kapke; Zachary Shaheen; Deepak Kilari; Paul Knudson; Stuart Wong
Journal:  Case Rep Oncol       Date:  2017-10-17

7.  Appropriate Insulin Level in Selecting Fortified Diet-Fed, Streptozotocin-Treated Rat Model of Type 2 Diabetes for Anti-Diabetic Studies.

Authors:  Stanley Irobekhian Reuben Okoduwa; Ismaila A Umar; Dorcas B James; Hajiya M Inuwa
Journal:  PLoS One       Date:  2017-01-27       Impact factor: 3.240

Review 8.  Immune modulation in humans: implications for type 1 diabetes mellitus.

Authors:  Bart O Roep; Timothy I M Tree
Journal:  Nat Rev Endocrinol       Date:  2014-01-28       Impact factor: 43.330

9.  Extent of beta cell destruction is important but insufficient to predict the onset of type 1 diabetes mellitus.

Authors:  David J Klinke
Journal:  PLoS One       Date:  2008-01-02       Impact factor: 3.240

10.  Coreceptor therapy has distinct short- and long-term tolerogenic effects intrinsic to autoreactive effector T cells.

Authors:  Matthew Clark; Charles J Kroger; Qi Ke; Rui Zhang; Karen Statum; J Justin Milner; Aaron Martin; Bo Wang; Roland Tisch
Journal:  JCI Insight       Date:  2021-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.